<DOC>
	<DOC>NCT01501695</DOC>
	<brief_summary>The purpose of this study is to evaluate the effective and safety of 5LGr in pediatric patients with tic disorders.</brief_summary>
	<brief_title>Phase III Study of 5LGr to Treat Tic Disorder</brief_title>
	<detailed_description>5LGr is a kind of traditional Chinese medicine(TCM) which under the direction of TCM theory.The aim of this study is prove the effective and safety of 5LGr in children and adolescence of Tic syndrome sub-population with specific TCM syndrome differentiation, when compared with tiapride and placebo.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Tic Disorders</mesh_term>
	<mesh_term>Tics</mesh_term>
	<mesh_term>Tiapride Hydrochloride</mesh_term>
	<criteria>&gt;1 year history of diagnosed tic disorder; age:518 yrs; YGTSS score&gt;=30 at baseline. Diagnosed with hyperactivity disorder,epilepsy,chorea,autism,obsessivecompulsive disorder,mental retardation,athetosis,Wilson's disease. Any indefinite tic disorder or tic disorders caused by medication. Participation to other studies. Patients with loose stool.</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>tic disorder</keyword>
	<keyword>pediatric</keyword>
</DOC>